Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Multiple Myeloma, Neoplasm Metastasis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical Trials

REPAINT

FLAURA

INFINITE

A Phase II Study of Atezolizumab in Combination With Bevacizumab, Carboplatin or Cisplatin, and Pemetrexed for EGFR-mutant Metastatic Non-small Cell Lung Cancer Patients After Failure of EGFR Tyrosine Kinase Inhibitors.

INSPECT

Natural Killer Cells and Bortezomib to Treat Cancer

AURA

A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

LUNGevity: Lung Cancer Stigma Community Based Participatory Research

Implementation of a System-level Tobacco Treatment Intervention

Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study

Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

PR-LUNGCA-2019

ENSPIRIT

Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

ASTEROID

LuPARP

UG3 Pilot Clinical Trial

RAMPART

A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery

MSC-LC

Efficacy of a Self-Efficacy Nursing Model in CyberKnife-Treated Lung Cancer Patients

Phase Ib of L-NMMA and Pembrolizumab

SPRINT

A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

RAD001

ATLANTIC

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free

SKYSCRAPER-02

358

Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors

Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

GeoMETry-C

DOPACER

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

SCLC-MDT

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

STALKLUNG01

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

TRADE-hypo

MyLungHealth

AIR

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer